HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Leo 271 f
structure
Also Known As:
estromustine; estrone 17 beta-3-N-bis(2-chloroethyl)carbamate; 3-(((bis(2-chloroethyl)amino)carbonyl)oxy)estra-1,3,5(10)-trien-17-one
Networked:
9
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Polycyclic Compounds: 6
Fused-Ring Compounds
Steroids: 70059
Ketosteroids: 23
17-Ketosteroids: 611
Estrone: 1105
Leo 271 f: 9
Estranes
Estrenes
Estrone: 1105
Leo 271 f: 9
Hormones, Hormone Substitutes, and Hormone Antagonists
Hormones: 80400
Adrenal Cortex Hormones: 62914
17-Ketosteroids: 611
Estrone: 1105
Leo 271 f: 9
Gonadal Hormones: 716
Gonadal Steroid Hormones: 7657
Estradiol Congeners: 358
Estrone: 1105
Leo 271 f: 9
Organic Chemicals: 133
Hydrocarbons: 1713
Halogenated Hydrocarbons: 42
Mustard Compounds: 3
Nitrogen Mustard Compounds: 2
Leo 271 f: 9
Related Diseases
1.
Neoplasms (Cancer)
01/01/1991 - "
[3H]Estromustine was bound to cytosols and salt extracts from tumors with the same affinity and displayed similar surface-charge distribution, sedimentation behavior, and subunit composition as found for ventral and dorsolateral prostatic tissue from tumor-bearing rats.
"
05/01/1991 - "
Our findings suggest that a mechanism for selective uptake of cytotoxic estramustine and estromustine is prevailing in these malignancies and that monitoring of EMBP in biopsy samples will be of value in defining patients who may benefit from Estracyt treatment.
"
01/01/1991 - "
The presence of high-affinity sites for estramustine and estromustine in human pancreatic carcinomas make this type of tumor a possible target tissue for compounds that exert antiproliferative as well as antimitotic activity in vitro.
"
05/01/1987 - "
The main route of action is considered to be not related to the steroid receptor but to the retention of Estramustine (EM-2), Estromustine (EM-1), and Estradiol (E2) in tumor tissues.
"
09/01/1998 - "
We have, therefore, examined the level of the four metabolites, estromustine (EoM), estramustine (EaM), estrone, and estradiol in the tumor and serum of 14 patients with T2 and T3 prostate cancer receiving a single i.v. dose of 600 mg of EMP, about 12 h before radical prostatectomy.
"
2.
Carcinoma (Carcinomatosis)
11/01/1988 - "
The uptake and binding of estramustine and estromustine in the tumour may account for the clinical effects of estracyt in prostatic carcinoma.
"
08/15/1988 - "
It binds specifically estramustine and estromustine, the cytotoxic metabolites of estramustine phosphate (Estracyt), a drug which is used in the treatment of prostatic carcinoma.
"
08/01/1995 - "
EMBP binds estramustine and estromustine, the active metabolites of estramustine phosphate (Estracyt), which is a drug with antimitotic properties used in the treatment of prostatic carcinoma.
"
11/01/1988 - "
Plasma and tumour concentrations of estramustine, estromustine, estradiol and estrone, the major metabolites of estramustine phosphate (estracyt), were determined in patients with prostatic carcinoma treated between one and nine years with repeated oral doses of estracyt (560 to 840 mg./day).
"
3.
Prostatic Neoplasms (Prostate Cancer)
03/01/1984 - "
There is a large amount of estramustine binding protein (EMBP) in the cytosol 3.5 S fraction of human prostatic cancer tissue, which is involved with the selective uptake and long term retention of both estramustine and estromustine in prostate.
"
09/01/1998 - "
We have, therefore, examined the level of the four metabolites, estromustine (EoM), estramustine (EaM), estrone, and estradiol in the tumor and serum of 14 patients with T2 and T3 prostate cancer receiving a single i.v. dose of 600 mg of EMP, about 12 h before radical prostatectomy.
"
4.
Pancreatic Neoplasms (Pancreatic Cancer)
01/01/1991 - "
The presence of high-affinity sites for estramustine and estromustine in human pancreatic carcinomas make this type of tumor a possible target tissue for compounds that exert antiproliferative as well as antimitotic activity in vitro.
"
5.
Ovarian Neoplasms (Ovarian Cancer)
05/01/1991 - "
The expression of the estramustine/estromustine-binding protein (EMBP) in human mammary cancer and malignant melanoma was examined by immunochemical methods and compared with that in endometrial and ovarian cancers.
"
Related Drugs and Biologics
1.
Estramustine
2.
Phosphates (Orthophosphate)
3.
Estradiol (Delestrogen)
4.
estramustine-binding protein
5.
Antimitotic Agents
6.
Estrone
7.
Salts
8.
Steroid Receptors (Steroid Receptor)
9.
Proteins (Proteins, Gene)
10.
Carrier Proteins (Binding Protein)
Related Therapies and Procedures
1.
Prostatectomy (Retropubic Prostatectomy)